Nitrendipine and other calcium channel blokers acutely inhibit hypoxic pulmonary vasoconstriction and show promise in the prevention of the pulmonary vascular and cardiac changes produced by chronic alveolar hypoxia. This paper reviews the current information available from animal and clinical studies.
|Original language||English (US)|
|Journal||Journal of cardiovascular pharmacology|
|State||Published - Jan 1 1987|
- Alveolar hypoxia
- Pulmonary and cardiac changes
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine